Vaccines and Public Health | Johns Hopkins | Bloomberg School of Public Health

Vaccines Headlines

Explore the latest public health research and insights about vaccines.

What You Need to Know About XBB.1.5, the Latest Omicron Variant

January 06, 2023

XBB.1.5 is the most transmissible variant of COVID-19 yet. As 2023 begins, it’s causing the majority of cases in the U.S., but we aren’t seeing a surge like omicron caused last winter.

How Human Challenge Trials Accelerate Vaccine Development

March 13, 2023

Vaccinated, intentionally infected, and sequestered in a hospital unit, volunteers help researchers fast-track promising vaccine candidates.

Bloomberg School of Public Health building exterior

Johns Hopkins Bloomberg School of Public Health Wins Six Anthem Awards

February 20, 2023

Winning work spans vaccines, tobacco control, gun violence, and communication about public health issues more broadly.

a vial labeled COVID-19 BA.4/BA.5 Bivalent Booster injection only, with a syringe next to it

Have Questions About the Bivalent Booster? We Have Answers.

February 13, 2023

Answers to common questions about the bivalent booster, including “Do I really need to get it?”

Peter Hotez on Patent-Free Vaccines—and Texas, Tito’s, and Twitter

January 25, 2023

Peter Hotez—with his signature uniform of lab-coat-and-bow-tie—has been a prominent voice on vaccine equity and misinformation throughout the COVID-19 pandemic.

3-dimensional numbers 2022, with a representation of SARS-CoV-2 in place of the number zero

COVID-19 in 2022: A Year-End Wrap-Up

December 15, 2022

As year three of the COVID-19 era draws to a close, pandemic experts weigh in on the good, the bad, and the unknown of COVID-19 in 2022—and look ahead to 2023.

Vaccines Faculty

Looking for prominent public health experts in the field of vaccines? They’re here at the Bloomberg School of Public Health.

William John Moss

Professor

Epidemiology

Anna P. Durbin

Professor

International Health

Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.

Daniel Salmon

Professor

International Health

Daniel Salmon, PhD ’03, MPH, is a vaccinologist who conducts epidemiological and behavioral studies to assess the safety of vaccines and improve vaccine decision-making.

Ruth Karron

Professor

International Health

Vaccines

Vaccines Headlines

What You Need to Know About XBB.1.5, the Latest Omicron Variant

How Human Challenge Trials Accelerate Vaccine Development

Johns Hopkins Bloomberg School of Public Health Wins Six Anthem Awards

Have Questions About the Bivalent Booster? We Have Answers.

Peter Hotez on Patent-Free Vaccines—and Texas, Tito’s, and Twitter

COVID-19 in 2022: A Year-End Wrap-Up

Vaccines Faculty

William John Moss

Anna P. Durbin

Daniel Salmon

Ruth Karron

Departments

Programs

Centers & Institutes

Upcoming Events

Vaccine Day 2023